Treatment with the senolytics dasatinib/quercetin reduces SARS-CoV-2-related mortality in mice.


Journal

Aging cell
ISSN: 1474-9726
Titre abrégé: Aging Cell
Pays: England
ID NLM: 101130839

Informations de publication

Date de publication:
03 2023
Historique:
revised: 07 12 2022
received: 22 04 2022
accepted: 20 12 2022
pubmed: 28 1 2023
medline: 17 3 2023
entrez: 27 1 2023
Statut: ppublish

Résumé

The enormous societal impact of the ongoing COVID-19 pandemic has been particularly harsh for some social groups, such as the elderly. Recently, it has been suggested that senescent cells could play a central role in pathogenesis by exacerbating the pro-inflammatory immune response against SARS-CoV-2. Therefore, the selective clearance of senescent cells by senolytic drugs may be useful as a therapy to ameliorate the symptoms of COVID-19 in some cases. Using the established COVID-19 murine model K18-hACE2, we demonstrated that a combination of the senolytics dasatinib and quercetin (D/Q) significantly reduced SARS-CoV-2-related mortality, delayed its onset, and reduced the number of other clinical symptoms. The increase in senescent markers that we detected in the lungs in response to SARS-CoV-2 may be related to the post-COVID-19 sequelae described to date. These results place senescent cells as central targets for the treatment of COVID-19, and make D/Q a new and promising therapeutic tool.

Identifiants

pubmed: 36704839
doi: 10.1111/acel.13771
pmc: PMC10014049
doi:

Substances chimiques

Quercetin 9IKM0I5T1E
Dasatinib RBZ1571X5H
Senotherapeutics 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13771

Informations de copyright

© 2023 The Authors. Aging Cell published by Anatomical Society and John Wiley & Sons Ltd.

Références

J Immunol. 1994 Dec 1;153(11):4969-77
pubmed: 7525719
Emerg Microbes Infect. 2020 Dec;9(1):2433-2445
pubmed: 33073694
Nat Commun. 2020 Nov 30;11(1):6122
pubmed: 33257679
Intensive Care Med. 2020 May;46(5):846-848
pubmed: 32125452
Cytokine. 2015 Sep;75(1):38-50
pubmed: 26187331
J Cell Biol. 2018 Jan 2;217(1):65-77
pubmed: 29114066
J Virol. 2007 Jan;81(2):813-21
pubmed: 17079315
J Clin Invest. 2018 Apr 2;128(4):1247-1254
pubmed: 29608140
Aging (Albany NY). 2020 Mar 11;12(5):4052-4066
pubmed: 32160592
J Infect Dis. 2021 Aug 2;224(3):395-406
pubmed: 33493287
PLoS Pathog. 2021 Jan 19;17(1):e1009195
pubmed: 33465158
Aging Cell. 2020 Oct;19(10):e13237
pubmed: 32955770
Sci Rep. 2020 Oct 29;10(1):18689
pubmed: 33122784
Aging (Albany NY). 2020 Jun 12;12(11):10004-10021
pubmed: 32534452
Nature. 2021 Nov;599(7884):283-289
pubmed: 34517409
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Aging Cell. 2019 Jun;18(3):e12950
pubmed: 30907060
Aging Cell. 2023 Mar;22(3):e13771
pubmed: 36704839
Metabolism. 2020 Jul;108:154262
pubmed: 32422233
J Allergy Clin Immunol. 2020 Jul;146(1):119-127.e4
pubmed: 32360286
J Intern Med. 2020 Nov;288(5):518-536
pubmed: 32686219
Science. 2021 Jul 16;373(6552):
pubmed: 34103349
Nature. 2021 Jun;594(7862):259-264
pubmed: 33887749
Front Pharmacol. 2021 Feb 04;11:600369
pubmed: 33613280
Sci Rep. 2021 Mar 29;11(1):7052
pubmed: 33782412
Cancer Treat Res Commun. 2021;28:100399
pubmed: 34023769
Aging (Albany NY). 2020 Jun 25;12(12):11337-11348
pubmed: 32584785
JCI Insight. 2020 Jun 18;5(12):
pubmed: 32427582
Sci Rep. 2017 Jun 16;7(1):3698
pubmed: 28623253
Nature. 1990 Oct 18;347(6294):669-71
pubmed: 1699135
Eur Respir J. 2022 Aug 18;60(2):
pubmed: 35086840
Nat Commun. 2017 Feb 23;8:14532
pubmed: 28230051
JCI Insight. 2021 Aug 9;6(15):
pubmed: 34185704
Front Immunol. 2021 Jun 21;12:677008
pubmed: 34234779
J Infect. 2020 Jun;80(6):607-613
pubmed: 32283152
Nature. 2021 Jan;589(7843):603-607
pubmed: 33166988
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
JCI Insight. 2020 Oct 2;5(19):
pubmed: 32841215
Nat Neurosci. 2019 May;22(5):719-728
pubmed: 30936558
Front Immunol. 2021 Dec 06;12:763292
pubmed: 34938289
Cells. 2020 Apr 08;9(4):
pubmed: 32276453
J Virol. 2010 Feb;84(3):1289-301
pubmed: 19906920
JCI Insight. 2020 Jul 9;5(13):
pubmed: 32501293
Nat Immunol. 2020 Nov;21(11):1327-1335
pubmed: 32839612

Auteurs

Andrés Pastor-Fernández (A)

Metabolic Syndrome Group-BIOPROMET, Madrid Institute for Advanced Studies-IMDEA Food, CEI UAM+CSIC, Madrid, Spain.

Antonio R Bertos (AR)

Department of Internal Medicine and Surgical Animal, Faculty of Veterinary/VISAVET Centre, Complutense University of Madrid, Madrid, Spain.

Arantzazu Sierra-Ramírez (A)

Metabolic Syndrome Group-BIOPROMET, Madrid Institute for Advanced Studies-IMDEA Food, CEI UAM+CSIC, Madrid, Spain.

Javier Del Moral-Salmoral (J)

Departamento de Biología Molecular, Universidad Autónoma de Madrid (UAM), Madrid, Spain.
Centro de Biología Molecular Severo Ochoa (CSIC-UAM), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.

Javier Merino (J)

Departamento de Biología Molecular, Universidad Autónoma de Madrid (UAM), Madrid, Spain.
Centro de Biología Molecular Severo Ochoa (CSIC-UAM), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.

Ana I de Ávila (AI)

Centro de Biología Molecular Severo Ochoa (CSIC-UAM), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, Madrid, Spain.

Cristina Olagüe (C)

Division of Gene Therapy and Regulation of Gene Expression, CIMA Universidad de Navarra, Pamplona, Spain.

Ricardo Villares (R)

Centro Nacional de Biotecnología (CNB-CSIC), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.

Gloria González-Aseguinolaza (G)

Division of Gene Therapy and Regulation of Gene Expression, CIMA Universidad de Navarra, Pamplona, Spain.

María Ángeles Rodríguez (MÁ)

Institute of Biomedicine of Seville (IBiS), Spanish National Research Council (CSIC), University of Seville, Virgen del Rocio University Hospital, Seville, Spain.

Manuel Fresno (M)

Departamento de Biología Molecular, Universidad Autónoma de Madrid (UAM), Madrid, Spain.
Centro de Biología Molecular Severo Ochoa (CSIC-UAM), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.

Nuria Gironés (N)

Departamento de Biología Molecular, Universidad Autónoma de Madrid (UAM), Madrid, Spain.
Centro de Biología Molecular Severo Ochoa (CSIC-UAM), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.

Matilde Bustos (M)

Institute of Biomedicine of Seville (IBiS), Spanish National Research Council (CSIC), University of Seville, Virgen del Rocio University Hospital, Seville, Spain.

Cristian Smerdou (C)

Division of Gene Therapy and Regulation of Gene Expression, CIMA Universidad de Navarra, Pamplona, Spain.

Pablo Jose Fernandez-Marcos (PJ)

Metabolic Syndrome Group-BIOPROMET, Madrid Institute for Advanced Studies-IMDEA Food, CEI UAM+CSIC, Madrid, Spain.

Cayetano von Kobbe (C)

Centro de Biología Molecular Severo Ochoa (CSIC-UAM), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH